Brii Biosciences Limited Stock Analysis
| BRIBF Stock | USD 0.13 0.00 0.00% |
Brii Biosciences Limited is overvalued with Real Value of 0.11 and Hype Value of 0.13. The main objective of Brii Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Brii Biosciences Limited is worth, separate from its market price. There are two main types of Brii Biosciences' stock analysis: fundamental analysis and technical analysis.
The Brii Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brii Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Brii |
Brii Pink Sheet Analysis Notes
About 53.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Brii Biosciences recorded a loss per share of 1.42. The entity had not issued any dividends in recent years. Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States.The quote for Brii Biosciences Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Brii Biosciences Limited go to https://www.briibio.com.Brii Biosciences Investment Alerts
| Brii Biosciences generated a negative expected return over the last 90 days | |
| Brii Biosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.16 B) with profit before overhead, payroll, taxes, and interest of 92.54 M. | |
| Brii Biosciences Limited has accumulated about 3.22 B in cash with (879.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Brii Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 941.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brii Biosciences's market, we take the total number of its shares issued and multiply it by Brii Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Brii Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Brii Biosciences Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Brii Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Brii Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Brii Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Brii Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brii shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Brii Biosciences. By using and applying Brii Pink Sheet analysis, traders can create a robust methodology for identifying Brii entry and exit points for their positions.
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Brii Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |